Spacer

 
 
Licensing & Royalties >> Licensing Opportunities >> Abstract Details
spacer
 
Bookmark and Share Print This Abstract Apply Questions ?
Potent, Easy to Use Targeted Toxins as Anti-Tumor Agents

Description of Invention:
The invention discloses synthesis and use of novel derivatives of 2-[2'-(2-aminoethyl)-2-methyl-ethyl]-l,2-dihydro-6-methoxy-3H-dibenz-[de,h]isoquinoline-l,3-dione as targeted anti-tumor agents. The use of targeted toxin conjugates with anti-cancer antibodies, such as herceptin, is increasing. Based on a comparison with the structurally complex toxins, such as DM1, available in the market, these novel toxins are more stable in circulation, thus making the toxin-conjugates more tumor-selective and less toxic. As such, these compounds are superior alternatives to the existing toxins.

The invention describes a potent and easy to synthesize toxin that can be used for generating a variety of prodrugs. These compounds can be attached to a ligand that recognizes a receptor on cancer cells, or to a peptide that is cleaved by tumor-specific proteases. The compounds are topoisomerase inhibitors and are mechanistically different from DM1 that targets tubulin.

The structure of the toxin allows it to be modified with a peptide linker that is stable, but rapidly cleaved in lysosomes after the compound is specifically taken up by cancer cells.

Applications:
The compounds can be used for preparation of a variety of potent anti-cancer agents with low systemic toxicity.

Advantages:
  • Easy to prepare
  • Structural features make these compounds more stable in circulation
  • Toxin conjugates are more tumor-selective and less toxic


Development Status:
  • In vitro data available
  • In vivo data available (animal)


Inventors:
Nadya I Tarasova (NCI)


Patent Status:
HHS, Reference No. E-160-2006/0
US, , Patent No. 8,008,316, Issued 30 Aug 2011
PCT, Application No. PCT/US2007/078233 filed 12 Sep 2007



For Licensing Information Please Contact:
Jennifer Wong
NIH Office of Technology Transfer
6011 Executive Blvd. Suite 325,
Rockville, MD 20852
United States
Email: wongje@mail.nih.gov
Phone: 301-435-4633
Fax: 301-402-0220


Ref No: 1570

Updated: 03/2012

 

 
 
 
Spacer
Note that this site uses cookies, Click here for more information.